PharmSelex's Unattributed Round

PharmSelex raised a round of funding on November 14, 2008. Investors include The Accelerator Group.

PharmaSelex (fka:GPC-Rx) focuses on the structure prediction of G-protein coupled receptors (GPCRs) to develop new GPCR-targeting drugs with reduced toxicity and enhanced selectivity. GPCRs are cell s…

Articles about PharmSelex's Unattributed Round: